The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Ectopic Expression of Cdc25A Accelerates the G 1 /S Transition and Leads to Premature Activation of Cyclin E- and Cyclin A-Dependent Kinases
Open accessAbstract
Human Cdc25 phosphatases play important roles in cell cycle regulation by removing inhibitory phosphates from tyrosine and threonine residues of cyclin-dependent kinases. Three human Cdc25 isoforms, A, B, and C, have been discovered. Cdc25B and Cdc25C play crucial roles at the G(2)/M transition. In the present study, we have investigated the function of human Cdc25A phosphatase. Cell lines that express human Cdc25A in an inducible manner have been generated. Ectopic expression of Cdc25A accelerates the G(1)/S-phase transition, indicating that Cdc25A controls an event(s) that is rate limiting for entry into S phase. Furthermore, we carried out a detailed analysis of the expression and activation of human Cdc25A. Activation of endogenous Cdc25A occurs during late G(1) phase and increases in S and G(2) phases. We further demonstrate that Cdc25A is activated at the same time as cyclin E- and cyclin A-dependent kinases. In vitro, Cdc25A dephosphorylates and activates the cyclin-Cdk complexes that are active during G(1). Overexpression of Cdc25A in the inducible system, however, leads to a premature activation of both cyclin E-Cdk2 and cyclin A-Cdk2 complexes, while no effect of cyclin D-dependent kinases is observed. Furthermore, Cdc25A overexpression induces a tyrosine dephosphorylation of Cdk2. These results suggest that Cdc25A is an important regulator of the G(1)/S-phase transition and that cyclin E- and cyclin A-dependent kinases act as direct targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
Antibodies: A laboratory manual
J.L. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90307-1 · Cited by 5,089
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 2×
“The pUHD 10-3 plasmid contains several repeats of the tetracycline operator linked to a cytomegalovirus minimal promoter (10).”
BackgroundInhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
CYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259
D-type cyclin-dependent kinase activity in mammalian cells.
Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,064
Resnitzky, D., Gossen, M., Bujard, H., & Reed, S. I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1669-1679.1994 · Cited by 965
cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2
Gautier, J., Solomon, M. J., Booher, R. N., Bazan, J. F., & Kirschner, M. W. (1991) · Cell · doi:10.1016/0092-8674(91)90583-k · Cited by 841
Draetta, G., & Beach, D. (1988) · Cell · doi:10.1016/0092-8674(88)90175-4 · Cited by 775
Mueller, P. R., Coleman, T. R., Kumagai, A., & Dunphy, W. G. (1995) · Science · doi:10.1126/science.270.5233.86 · Cited by 695
Cdc25 cell-cycle phosphatase as a target of c-myc
Galaktionov, K., Chen, X., & Beach, D. (1996) · Nature · doi:10.1038/382511a0 · Cited by 690
Hoffmann, I., Clarke, P. R., Marcote, M. J., Karsenti, E., & Draetta, G. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05631.x · Cited by 684
Self-citationResnitzky, D., Gossen, M., Bujard, H., & Reed, S. I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1669 · Cited by 664
Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.
Gu, Y., Rosenblatt, J., & Morgan, D. O. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05493.x · Cited by 642
Galaktionov, K., & Beach, D. (1991) · Cell · doi:10.1016/0092-8674(91)90294-9 · Cited by 505
CDC25 Phosphatases as Potential Human Oncogenes
Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., & Beach, D. (1995) · Science · doi:10.1126/science.7667636 · Cited by 504
Hoffmann, I., Draetta, G., & Karsenti, E. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06750.x · Cited by 494
Self-citationHuman Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15.
McGowan, C. H., & Russell, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05633.x · Cited by 493
Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F
Leone, G., DeGregori, J., Sears, R., Jakoi, L., & Nevins, J. R. (1997) · Nature · doi:10.1038/387422a0 · Cited by 468
Cdc25A is a novel phosphatase functioning early in the cell cycle.
Jinno, S., Suto, K., Nagata, A., Igarashi, M., Kanaoka, Y., Nojima, H., & Okayama, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06417.x · Cited by 452
lavarone, A., & Massagué, J. (1997) · Nature · doi:10.1038/387417a0 · Cited by 377
Liu, F., Stanton, J. J., Wu, Z., & Piwnica-Worms, H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.571 · Cited by 376
Poon, R. Y., Yamashita, K., Adamczewski, J. P., Hunt, T., & Shuttleworth, J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05981.x · Cited by 376
Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2.
Sadhu, K., Reed, S. I., Richardson, H., & Russell, P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5139 · Cited by 350
CAK, the p34cdc2 activating kinase, contains a protein identical or closely related to p40MO15.
Solomon, M. J., Harper, J. W., & Shuttleworth, J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05982.x · Cited by 326
The cdc25B phosphatase is essential for the G 2/M phase transition in human cells
Lammer1, C., Wagerer, S., Saffrich, R., Mertens, D., Ansorge, W., & Hoffmann, I. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.16.2445 · Cited by 306
Self-citationElimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase.
Izumi, T., & Maller, J. L. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.12.1337 · Cited by 298
Crystal Structure of the Catalytic Domain of the Human Cell Cycle Control Phosphatase, Cdc25A
Fauman, E. B., Cogswell, J. P., Lovejoy, B., Rocque, W. J., Holmes, W., Montana, V. G., Piwnica-Worms, H., Rink, M. J., & Saper, M. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81190-3 · Cited by 286
Resnitzky, D., Hengst, L., & Reed, S. I. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4347 · Cited by 246
Gabrielli, B. G., Souza, C. P. C. D., Tonks, I. D., Clark, J. M., Hayward, N. K., & Ellem, K. A. O. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.5.1081 · Cited by 236
p55CDC25 is a nuclear protein required for the initiation of mitosis in human cells.
Millar, J. B. A., Blevitt, J. M., Gerace, L., Sadhu, K., Featherstone, C., & Russell, P. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10500 · Cited by 234
Nagata, A., Igarashi, M., Jinno, S., et al. (1991) · PubMed · Cited by 199
Requirement for tyrosine phosphorylation of Cdk4 in Gl arrest induced by ultraviolet irradiation
Terada, Y., Tatsuka, M., Jinno, S., & Okayama, H. (1995) · Nature · doi:10.1038/376358a0 · Cited by 186
Coqueret, O., Bérubé, G., & Nepveu, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4680 · Cited by 171
Strausfeld, U., Fernandez, A., Capony, J. P., Girard, F., Lautredou, N., Derancourt, J., Labbe, J. C., & Lamb, N. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37560-9 · Cited by 161
p21CIP1 and Cdc25A: Competition between an Inhibitor and an Activator of Cyclin-Dependent Kinases
Saha, P., Eichbaum, Q. G., Silberman, E. D., Mayer, B. J., & Dutta, A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4338 · Cited by 112
Cyclin-dependent kinase inhibitors
Harper, J. W. (2025) · Reactions Weekly · doi:10.1007/s40278-025-91549-1 · Cited by 90
Nishijima, H., Nishitani, H., Seki, T., & Nishimoto, T. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.5.1105 · Cited by 88
Xu, X., & Burke, S. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.5118 · Cited by 71
Activity and nature of p21 WAF1 complexes during the cell cycle
Cai, K., & Dynlacht, B. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12254 · Cited by 61
Cyclin–dependent protein kinases and the regulation of the eukaryotic cell cycle
Hoffmann, I. (1996) · Wiley eBooks · doi:10.1002/9783527615032.ch6 · Cited by 3
Self-citation
Cited by
Human papillomavirus oncoproteins: pathways to transformation
Moody, C. A., & Laimins, L. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2886 · Cited by 1,751
CDC25 phosphatases in cancer cells: key players? Good targets?
Boutros, R., Lobjois, V., & Ducommun, B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2169 · Cited by 714
Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle
Ekholm, S. V., & Reed, S. I. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00151-4 · Cited by 588
Sørensen, C. S., Syljuåsen, R. G., Falck, J., Schroeder, T., Rönnstrand, L., Khanna, K. K., Zhou, B.-B., Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00048-5 · Cited by 559
Zhao, H., Watkins, J. L., & Piwnica-Worms, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182557299 · Cited by 461
Metadata
- Authors
- Blomberg, I., & Hoffmann, I.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1999-09
- Volume
- 19
- Issue
- 9
- Pages
- 6183-6194
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2113670632
- Cited by
- 291
- References
- 41
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.